Schonfeld Strategic Advisors’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $61.2K | Sell |
196,660
-4,476,953
| -96% | -$1.39M | ﹤0.01% | 1770 |
|
2025
Q1 | $2.28M | Sell |
4,673,613
-4,088,678
| -47% | -$2M | 0.01% | 795 |
|
2024
Q4 | $7.5M | Buy |
8,762,291
+8,419,781
| +2,458% | +$7.21M | 0.04% | 358 |
|
2024
Q3 | $2.91M | Sell |
342,510
-191,219
| -36% | -$1.63M | 0.02% | 622 |
|
2024
Q2 | $2.49M | Sell |
533,729
-1,302,913
| -71% | -$6.08M | 0.02% | 705 |
|
2024
Q1 | $12.5M | Buy |
1,836,642
+1,345,151
| +274% | +$9.15M | 0.08% | 264 |
|
2023
Q4 | $1.65M | Buy |
491,491
+34,091
| +7% | +$114K | 0.01% | 803 |
|
2023
Q3 | $1.14M | Buy |
+457,400
| New | +$1.14M | 0.01% | 862 |
|
2022
Q2 | – | Sell |
-30,500
| Closed | -$65K | – | 2426 |
|
2022
Q1 | $65K | Buy |
+30,500
| New | +$65K | ﹤0.01% | 2237 |
|